A global beauty company, Evolus, Inc. (NASDAQ: EOLS), based in Newport Beach, California, revealed its plan to launch Estyme® in Europe on May 16th. Estyme® comprises four injectable hyaluronic acid (HA) gels, expanding the company's presence in the international dermal filler market. Designed to offer a broad spectrum of aesthetic solutions, this collection signifies Evolus's venture into diversifying its product portfolio.